ArticleCureus2025
Ramipril-Induced Isolated Small Bowel Angioedema: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Isolated small bowel angioedema is an uncommon adverse reaction to angiotensin-converting enzyme (ACE) inhibitors, predominantly affecting females. The nonspecific clinical presentation, along with the lack of definitive diagnostic laboratory and radiological findings, makes the diagnosis particularly challenging. We present the case of a 63-year-old female patient who developed diffuse abdominal pain and nausea just seven days after starting ramipril. The diagnosis of ACE inhibitor-induced small bowel angioedema was confirmed by a computed tomography (CT) scan of the abdomen and the pelvis, which revealed circumferential wall thickening and submucosal edema involving multiple jejunal loops. These findings were consistent with angioedema. The condition was successfully managed by discontinuing the medication, and the patient showed rapid clinical improvement within 48 hours of stopping ramipril. To our knowledge, this is only the second reported case of ramipril-induced isolated small bowel angioedema in the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.